Apogenix’ new CD40 agonist HERA-CD40L significantly reduces tumor growth in prostate cancer model
Preclinical data published in Frontiers in Immunology, a leading peer-reviewed journal Induction of pro-inflammatory…
Preclinical data published in Frontiers in Immunology, a leading peer-reviewed journal Induction of pro-inflammatory…
The global Whole Genome Amplification Market is estimated at around US$ 5.08 Bn by the end of 2031, as indicated by a re…
. - Seamless transition from R&D to commercial-scale additive manufacturing - Leading-edge cleanroom, no-touch manufac…
AESKU.GROUP announced today it completed acquisition of immunofluorescence assay (IFA) specialist MBL BION from MBL Intl…
Fresenius Medical Care, der weltweit führende Anbieter von Produkten und Dienstleistungen für Menschen mit Nierenerkrank…
Flow cytometry is used to monitor microscopic particles with the help of electronic devices called flow cytometers. Flow…
From 26 March 2018, SAP will provide access to the “Corporate Oncology Program for Employees” (COPE®), developed by Mole…
- Neueste Daten unterstützen die Fähigkeit der oralen T-Zell-Immuntherapie-Plattform zur Stimulierung einer Anti-Tumor-I…
New preclinical data in Cancer Immunology Research demonstrate that increasing tumor-infiltrating T cells through inhibi…
Neue präklinische Daten in der Fachzeitschrift Cancer Immunology Research zeigen, dass die Hemmung von CXCL12 durch NOX-…